A significant discovery in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This essential cancer inhibitor protein is frequently disabled in various forms of tumors, leading https://bookmarklinx.com/story22008151/nanobodies-reactivate-the-p53-protein-a-potential-pathway-for-cancer-therapy